What are "high-risk" grade 2 IDH-mutant gliomas requiring radiochemotherapy? Wen PY, Nakhate V, van den Bent MJ. Neuro Oncol 2026 Aug 19:noag197. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Wen PY, Nakhate V, van den Bent MJ. What are "high-risk" grade 2 IDH-mutant gliomas requiring radiochemotherapy? Neuro Oncol 2026 Aug 19:noag197. doi: 10.1093.
PMID: 42616660